Jørgensen K, Björnsson E, Sørensen M. "Method for the Synthesis of Pazopanib Impurity 45(Mixture of Isomers)" [P]. European Patent, EP 3354210 A1, 2023-04-27.
发明人沈红梅,胡光,陈志强. "A Process for Preparing High-Purity Pazopanib Impurity 45(Mixture of Isomers)" [P]. 中国发明专利, 专利号 CN 116121982 A, 授权公告日 2019-12-27.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 帕唑帕尼杂质45 (异构体混合物) in Pharmaceutical Formulations". Environ. Sci. Technol., 2014, 1020, (2), 3701-3727.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of 帕唑帕尼杂质45 (异构体混合物) as an Impurity". Food Chem., 2022, 1880, (3), 6080-6108.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Pazopanib Impurity 45(Mixture of Isomers) Using HRMS and NMR". Chemosphere, 2021, 1018, 1297-1316.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 帕唑帕尼杂质45 (异构体混合物) Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2022, 1572, (10), 339-362.